Company / Current Assets
AbbVie Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$29.1B
FY2025
5-year range
$25.6B / $33.0B
FY2021-FY2025
Trend
+13.6%
vs FY2024
Sector context
#6 of 215
Health Care
What the data says
Among 215 Health Care companies, AbbVie is in the top 3% for current assets. Current Assets has fluctuated over the past 10 years, ranging from $16.2B in FY2016 to $49.5B in FY2019.
Based on SEC 10-K filings.
$29.1B in FY2025 with a 5-year CAGR of +3.8%. Top quartile in the Health Care sector.
Declined from $33.0B to $29.1B over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +0.7%
- 5-Year CAGR
- +3.8%
- 10-Year CAGR
- -
Sector benchmark
Top 3% in Health CareTop 3% of 215This company $29.1B Sector average $2.5B
▼
+1047.5% above sector average
Key checks
Key Insights
- 5-year CAGR of +3.8%, indicating consistent growth.
- In FY2025, current assets increased 13.6% year-over-year.
- Ranks #6 out of 215 companies in the Health Care sector.
- Peak current assets was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score 0.62 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $29.1B | +13.6% |
| FY2024 | $25.6B | -22.5% |
| FY2023 | $33.0B | +15.9% |
| FY2022 | $28.5B | +1.9% |
| FY2021 | $27.9B | +15.5% |
| FY2020 | $24.2B | -51.2% |
| FY2019 | $49.5B | +192.2% |
| FY2018 | $16.9B | -20.2% |
| FY2017 | $21.2B | +31.1% |
| FY2016 | $16.2B | -0.8% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026